Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Factors associated with multi-drug resistant (Rifampin resistant) TB and drug susceptibility.

Mohamed Abdelrahman Mohamed (16949136)
Omer Abdikarin Ali (16949139)
Aamir Muse Osman (16949142)
Mustapha Goni Abatcha (16949145)
Abdirahman Abdirizak Ahmed (16949148)
Ali Mohamed Ali (16949151)
Abdifatah Ahmed Dirie (16949154)
Celso José Bruno de Oliveira (11497468)
Abdinasir Yusuf Osman (16949157)
Shu-Hua Wang (4726611)
Rafael F. C. Vieira (5624948)

Publication date

September 2023

DOI

10.1371/journal.pgph.0002319.t002

Abstract

Factors associated with multi-drug resistant (Rifampin resistant) TB and drug susceptibility.</p

Extracted data

Related items

Risk Factors for Multidrug-resistant Tuberculosis

Cleopas Martin Rumende

April 2018

In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...

Drug resistance patterns of <i>M</i>. <i>tuberculosis</i> in the TB-HIV coinfection group and the TB without HIV infection group.

Mi Zhou (9884)
Shan Liu (193759)
Qingfeng Li (1524259)
Qiming Wang (730892)
Ma Zhu (6166328)
Ling Cao (304475)
Dongmei Wang (282313)
Yuanhong Xu (346563)
Tianli Zheng (6166331)
Qian Ye (610320)
Xiuying Hu (1379238)
Haojiang Zuo (5875103)
Xiaofang Pei (5875106)

December 2018

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV i...

Emerg Infect Dis

To describe factors associated with multidrug-resistant (MDR), including extensively-drug-resistant ...

Multivariable analysis of factors associated with diagnostic and treatment delay of rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Multivariable analysis of factors associated with diagnostic and treatment delay of rifampicin-resis...

Prevalence of drug resistance to the different first-line anti-TB drugs investigated.

Henry D. Meriki (471451)
Kukwah A. Tufon (471452)
Pascal N. Atanga (471453)
Irene N. Ane-Anyangwe (471454)
Damian N. Anong (170313)
Fidelis Cho-Ngwa (191165)
Theresa Nkuo-Akenji (471455)

October 2013

<p>Prevalence of drug resistance to the different first-line anti-TB drugs investigated.</p

Univariate and multivariate analysis for factors associated with resistance to first line anti-tuberculosis drugs in Dar es salaam, Tanzania (n = 933).

Tumaini J. Nagu (538640)
Said Aboud (214830)
Ramadhani Mwiru (718419)
Mecky Matee (66135)
Wafaie Fawzi (538642)
Ferdinand Mugusi (214835)

April 2015

<p>Univariate and multivariate analysis for factors associated with resistance to first line anti-tu...

Factors associated with multidrug-resistant tuberculosis

Md Nurul Amin
Md Anisur Rahman
Meerjady Sabrina Flora
Md Abul Kalam Azad

January 2009

This case control study was conducted in selected centers of Dhaka City from March to July 2008 to d...

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.</p

Minimum inhibitory concentration of rifampin, rifabutin and isoniazid among multidrug resistant (MDR), rifampin resistant (RR) and isoniazid (INH) resistant <i>Mycobacterium tuberculosis</i> isolates.

Muluwork Getahun (6744347)
Henry M. Blumberg (7348961)
Gobena Ameni (357071)
Dereje Beyene (5334734)
Russell R. Kempker (7348955)

September 2022

Minimum inhibitory concentration of rifampin, rifabutin and isoniazid among multidrug resistant (MDR...

Role of Risk Factors in the Incidence of Multidrug-Resistant Tuberculosis

Alya Putri Khairani
Prayudi Santoso
Elsa Pudji Setiawati

September 2017

Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...

Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.

Helen S. Cox (80991)
Cheryl McDermid (335960)
Virginia Azevedo (335962)
Odelia Muller (359842)
David Coetzee (129367)
John Simpson (359843)
Marinus Barnard (359844)
Gerrit Coetzee (296078)
Gilles van Cutsem (93995)
Eric Goemaere (129370)

February 2013

<p>Univariate and multivariate analyses to assess associations with rifampicin resistance among all,...

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.

Sunil Khaparde (4419847)
Neeraj Raizada (52447)
Sreenivas Achuthan Nair (295840)
Claudia Denkinger (308888)
Kuldeep Singh Sachdeva (305148)
Chinnambedu Nainarappan Paramasivan (763725)
Virender Singh Salhotra (4419841)
Anna Vassall (144677)
Anja van't Hoog (4419844)

September 2017

<p>TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnos...

Drug resistance among Tuberculosis Re-Treatment Cases; Study on Drug Resistance/Multi-drug Resistance and associated risk factors for developing MDR among Tuberculosis Re-Treatment Cases in Khartoum State

Obeidalla, Imad El Amin

January 2005

Sudan TB Reference laboratory need more strengthening in issue of cultures and drug susceptibility t...

Identification of risk factors for MDR TB among patients with pulmonary tuberculosis : a case control study in Karachi, Pakistan /

Ahmad, Ahsan Maqbool

January 2002

Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...

Detection of rifampicin resistant TB using Xpert MTB/RIF, solid and liquid media DST within the same individuals at four provincial laboratories.

Sanne Christine van Kampen (771338)
Aigul Tursynbayeva (771339)
Aliya Koptleuova (771340)
Zauresh Murzabekova (771341)
Lyazzat Bigalieva (771342)
Moldir Aubakirova (771343)
Svetlana Pak (771344)
Susan van den Hof (364556)

July 2015

<p>Abbreviations: RIF, rifampicin; DST, drug-susceptibility testing.</p><p>Detection of rifampicin r...

Risk Factors for Multidrug-resistant Tuberculosis

Cleopas Martin Rumende

April 2018

In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...

Drug resistance patterns of <i>M</i>. <i>tuberculosis</i> in the TB-HIV coinfection group and the TB without HIV infection group.

Mi Zhou (9884)
Shan Liu (193759)
Qingfeng Li (1524259)
Qiming Wang (730892)
Ma Zhu (6166328)
Ling Cao (304475)
Dongmei Wang (282313)
Yuanhong Xu (346563)
Tianli Zheng (6166331)
Qian Ye (610320)
Xiuying Hu (1379238)
Haojiang Zuo (5875103)
Xiaofang Pei (5875106)

December 2018

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV i...

Emerg Infect Dis

To describe factors associated with multidrug-resistant (MDR), including extensively-drug-resistant ...

Multivariable analysis of factors associated with diagnostic and treatment delay of rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Multivariable analysis of factors associated with diagnostic and treatment delay of rifampicin-resis...

Prevalence of drug resistance to the different first-line anti-TB drugs investigated.

Henry D. Meriki (471451)
Kukwah A. Tufon (471452)
Pascal N. Atanga (471453)
Irene N. Ane-Anyangwe (471454)
Damian N. Anong (170313)
Fidelis Cho-Ngwa (191165)
Theresa Nkuo-Akenji (471455)

October 2013

<p>Prevalence of drug resistance to the different first-line anti-TB drugs investigated.</p

Univariate and multivariate analysis for factors associated with resistance to first line anti-tuberculosis drugs in Dar es salaam, Tanzania (n = 933).

Tumaini J. Nagu (538640)
Said Aboud (214830)
Ramadhani Mwiru (718419)
Mecky Matee (66135)
Wafaie Fawzi (538642)
Ferdinand Mugusi (214835)

April 2015

<p>Univariate and multivariate analysis for factors associated with resistance to first line anti-tu...

Factors associated with multidrug-resistant tuberculosis

Md Nurul Amin
Md Anisur Rahman
Meerjady Sabrina Flora
Md Abul Kalam Azad

January 2009

This case control study was conducted in selected centers of Dhaka City from March to July 2008 to d...

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.</p

Minimum inhibitory concentration of rifampin, rifabutin and isoniazid among multidrug resistant (MDR), rifampin resistant (RR) and isoniazid (INH) resistant <i>Mycobacterium tuberculosis</i> isolates.

Muluwork Getahun (6744347)
Henry M. Blumberg (7348961)
Gobena Ameni (357071)
Dereje Beyene (5334734)
Russell R. Kempker (7348955)

September 2022

Minimum inhibitory concentration of rifampin, rifabutin and isoniazid among multidrug resistant (MDR...

Role of Risk Factors in the Incidence of Multidrug-Resistant Tuberculosis

Alya Putri Khairani
Prayudi Santoso
Elsa Pudji Setiawati

September 2017

Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...

Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.

Helen S. Cox (80991)
Cheryl McDermid (335960)
Virginia Azevedo (335962)
Odelia Muller (359842)
David Coetzee (129367)
John Simpson (359843)
Marinus Barnard (359844)
Gerrit Coetzee (296078)
Gilles van Cutsem (93995)
Eric Goemaere (129370)

February 2013

<p>Univariate and multivariate analyses to assess associations with rifampicin resistance among all,...

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.

Sunil Khaparde (4419847)
Neeraj Raizada (52447)
Sreenivas Achuthan Nair (295840)
Claudia Denkinger (308888)
Kuldeep Singh Sachdeva (305148)
Chinnambedu Nainarappan Paramasivan (763725)
Virender Singh Salhotra (4419841)
Anna Vassall (144677)
Anja van't Hoog (4419844)

September 2017

<p>TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnos...

Drug resistance among Tuberculosis Re-Treatment Cases; Study on Drug Resistance/Multi-drug Resistance and associated risk factors for developing MDR among Tuberculosis Re-Treatment Cases in Khartoum State

Obeidalla, Imad El Amin

January 2005

Sudan TB Reference laboratory need more strengthening in issue of cultures and drug susceptibility t...

Identification of risk factors for MDR TB among patients with pulmonary tuberculosis : a case control study in Karachi, Pakistan /

Ahmad, Ahsan Maqbool

January 2002

Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...

Detection of rifampicin resistant TB using Xpert MTB/RIF, solid and liquid media DST within the same individuals at four provincial laboratories.

Sanne Christine van Kampen (771338)
Aigul Tursynbayeva (771339)
Aliya Koptleuova (771340)
Zauresh Murzabekova (771341)
Lyazzat Bigalieva (771342)
Moldir Aubakirova (771343)
Svetlana Pak (771344)
Susan van den Hof (364556)

July 2015

<p>Abbreviations: RIF, rifampicin; DST, drug-susceptibility testing.</p><p>Detection of rifampicin r...

Risk Factors for Multidrug-resistant Tuberculosis

Cleopas Martin Rumende

April 2018

In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...

Drug resistance patterns of <i>M</i>. <i>tuberculosis</i> in the TB-HIV coinfection group and the TB without HIV infection group.

Mi Zhou (9884)
Shan Liu (193759)
Qingfeng Li (1524259)
Qiming Wang (730892)
Ma Zhu (6166328)
Ling Cao (304475)
Dongmei Wang (282313)
Yuanhong Xu (346563)
Tianli Zheng (6166331)
Qian Ye (610320)
Xiuying Hu (1379238)
Haojiang Zuo (5875103)
Xiaofang Pei (5875106)

December 2018

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV i...

Emerg Infect Dis

To describe factors associated with multidrug-resistant (MDR), including extensively-drug-resistant ...